Study of MLN8237 in Combination With Irinotecan and Temozolomide
Clinical trial NCT01601535 · COMPLETED
Trial details
- NCT number
- NCT01601535
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2018-07-25
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.